Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. M. Jurgensmeier

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, Against VEGFR-1 and Members of the Structurally Related PDGFR Family

Molecular Cancer Therapeutics

Cancer Research

English

The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

Cancer Research

Cancer Research

English

Related publications

Analysis of Biological Effects and Signaling Properties of FLT-1 (VEGFR-1) and KDR (VEGFR-2)

Journal of Biological Chemistry

Molecular Biology

English

A Case Report of Successful Treatment of Metastatic Gastral Neuroendocrine Carcinoma to a Small-Molecule VEGFR-2 Tyrosine Kinase Inhibitor Apatinib

Biomedical Research

English

Inhibitor of DNA Binding 1 (ID1); VEGF Receptor 2 (KDR/Flk-1; VEGFR-2)

Science-Business eXchange

English

Generation and Characterization of a Human Nanobody Against VEGFR-2

Acta Pharmacologica Sinica

English

Specific Inhibition of the VEGFR-3 Tyrosine Kinase by SAR131675 Reduces Peripheral and Tumor Associated Immunosuppressive Myeloid Cells

Cancer Research

English

Combined Blockade of VEGFR-2 and VEGFR-3 Inhibits Inflammatory Lymphangiogenesis in Early and Middle Stages

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants

Journal of Nuclear Medicine

Nuclear Medicine

English

Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression

OncoTargets and Therapy

English